购物车
- 全部删除
- 您的购物车当前为空
Monensin is an antiprotozoal agent produced by Streptomyces cinnamonensis. It has an inhibitory effect on the Wnt/β-catenin signaling cascade. Monensin is a prospective anticancer drug for the therapy of neoplasia with deregulated Wnt signaling.
Monensin is an antiprotozoal agent produced by Streptomyces cinnamonensis. It has an inhibitory effect on the Wnt/β-catenin signaling cascade. Monensin is a prospective anticancer drug for the therapy of neoplasia with deregulated Wnt signaling.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50 mg | ¥ 7,158 | 5日内发货 |
产品描述 | Monensin is an antiprotozoal agent produced by Streptomyces cinnamonensis. It has an inhibitory effect on the Wnt/β-catenin signaling cascade. Monensin is a prospective anticancer drug for the therapy of neoplasia with deregulated Wnt signaling. |
别名 | 莫能菌素, Rumensin, Elancoban |
分子量 | 670.87 |
分子式 | C36H62O11 |
CAS No. | 17090-79-8 |
密度 | 1.21 g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | DMSO: Soluble |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容